Nicholas Kennedy

Appearances

HABITUAL MEAT INTAKE IS ASSOCIATED WITH INCREASED RISK OF DISEASE FLARE IN ULCERATIVE COLITIS: INITIAL RESULTS FROM THE PREDICCT STUDY
Date
May 7, 2023
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
Presenter
Charlie Lees
Speakers
Beatriz Gros
Janet Kyle
Nikolas Plevris
Lauranne Derikx
Nathan Constantine-Cooke
Gareth Jones
Phillip Jenkinson
Spyros Siakavellas
Lee Murphy
Nicholas Kennedy
Daniel Gaya
Lisa Derr
Graham Horgan
Christopher Weir
Alex Johnstone
Linda Williams
ENDOSCOPIC OUTCOMES WITH EARLY TREATMENT IN NEWLY-DIAGNOSED CROHN’S DISEASE: EVIDENCE FROM PROFILE, A MULTI-CENTRE, RANDOMIZED, OPEN-LABEL, BIOMARKER-STRATIFIED CLINICAL TRIAL
Date
May 21, 2024
Management strategies and clinical outcomes vary substantially in patients newly-diagnosed with Crohn’s disease…
Presenter
Nurulamin Noor
Speakers
James Lee
Simon Bond
Francis Dowling
Biljana Brezina
Kamal V Patel
Tariq Ahmad
Paul Banim
Rachel Cooney
Juan De La Revilla Negro
Shanika de Silva
Shahida Din
Dharmaraj Durai
John Gordon
Peter Irving
Matthew Johnson
Alexandra Kent
Klaartje Kok
Gordon Moran
Pritash Patel
Christopher Probert
Tim Raine
Rebecca Saich
Abigail Seward
Dan Sharpstone
Melissa Smith
Sreedhar Subramanian
Sara Upponi
Alan Wiles
Gijs van den Brink
Séverine Vermeire
Katholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven
Vipul Jairath
Western University
Geert D’Haens
Eoin McKinney
Paul Lyons
James Lindsay
Barts & The London School of Medicine and Dentistry
Nicholas Kennedy
Kenneth Smith
Miles Parkes